Early increased levels of matrix metalloproteinase-9 in neonates recovering from respiratory distress syndrome

Biology of the Neonate

Volumn 89, Issue 1, 2006, Pages 6-14

  Dik, Willem A ^a   Van Kaam, Anton H L C ^c   Dekker, Tamara ^d   Naber, Brigitta A E ^a,b   Janssen, Daphne J ^b   Kroon, A A ^b   Zimmermann, Luc J I ^e   Versnel, Marjan A ^a   Lutter, René ^d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c EMMA CHILDREN S HOSPITAL   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chronic lung disease of prematurity; Matrix metalloproteinase; Respiratory distress syndrome, neonatal

Indexed keywords

GELATINASE B; LIPOCALIN;

ARTICLE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DENSITOMETRY; DIAGNOSTIC PROCEDURE; EPITHELIUM CELL; GESTATIONAL AGE; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; LUNG LAVAGE; MACROPHAGE; NEUTROPHIL; NEWBORN; POSTNATAL CARE; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; ZYMOGRAPHY;

ACUTE-PHASE PROTEINS; AGING; BRONCHOALVEOLAR LAVAGE FLUID; CHRONIC DISEASE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INTENSIVE CARE, NEONATAL; LUNG; LUNG DISEASES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PROTO-ONCOGENE PROTEINS; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 30644465559     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088193     Document Type: Article

References (28)

1. Robertson B: The evolution of neonatal respiratory distress syndrome into chronic lung disease. Eur Respir J Suppl 1989;3:33s-37s.
2. Speer CP: New insights into the pathogenesis of pulmonary inflammation in preterm infants. Biol Neonate 2001;79:205-209.
3. Clark RH, Gerstmann DR, Jobe AH, Moffitt ST, Slutsky AS, Yoder BA: Lung injury in neonates: causes, strategies for prevention, and long- term consequences. J Pediatr 2001;139: 478-484.
4. Sweet DG, McMahon KJ, Curley AE, O'Connor CM, Halliday HL: Type I collagenases in bronchoalveolar lavage fluid from preterm babies at risk of developing chronic lung disease. Arch Dis Child Fetal Neonatal Ed 2001;84:F168-F171.
5. Cederqvist K, Sorsa T, Tervahartiala T, Maisi P, Reunanen K, Lassus P, Andersson S: Matrix metalloproteinases-2, -8, and -9 and TIMP-2 in tracheal aspirates from preterm infants with respiratory distress. Pediatrics 2001;108:686-692.
6. Dik WA, de Krijger RR, Bonekamp L, Naber BAE, Zimmermann LJI, Versnel MA: Localization and potential role of matrix metalloproteinase-1 and tissue inhibitors of metalloproteinase-1 and -2 in different phases of bronchopulmonary dysplasia. Pediatr Res 2001;50:763-768.
7. Collier IE, Wilhelm SM, Eisen AZ, Marmer BL, Grant GA, Seltzer JL, Kronberger A, He CS, Bauer EA, Goldberg GI: H-ras oncogene-transfonned human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J Biol Chem 1988;263:6579-6587.
8. Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant GA, Goldberg GI: SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989;264:17213-17221.
9. Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI, Welgus HG: Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem 1991;266:7870-7875.
10. Pardo A, Barrios R. Maldonado V, Melendez J, Perez J, Ruiz V, Segura-Valdez L, Sznajder JI, Selman M: Gelatinases A and B are up-regulated in rat lungs by subacute hyperoxia: pathogenetic implications. Am J Pathol 1998; 153:833-844.
11. Opdenakker G, Van den Steen PE, Van Damme J: Gelatinase B: A tuner and amplifier of immune functions. Trends Immunol 2001; 22:571-579.
12. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N: Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993;268: 10425-10432.
13. Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, Van Damme J: Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 2001;69:851-859.
14. Ricou B, Nicod L, Lacraz S, Welgus HG, Suter PM, Dayer JM: Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:346-352.
15. Torii K, Iida K, Miyazaki Y, Saga S, Kondoh Y, Taniguchi H, Taki F, Takagi K, Matsuyama M, Suzuki R: Higher concentrations of matrix metalloproteinases in bronchoalveolar lavage fluid of patients with adult respiratory distress syndrome. Am J Respir Crit Care Med 1997; 155:43-46.
16. Selman M, Ruiz V, Cabrera S, Segura L, Ramirez R, Barrios R, Pardo A: TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol 2000;279:L562-L574.
17. Corbel M. Caulet-Maugendre S, Germain N. Molet S, Lagente V, Boichot E: Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat. J Pathol 2001;193:538-545.
18. Schock BC, Sweet DG, Ennis M, Warner JA, Young IS, Halliday HL: Oxidative stress and increased type-IV collagenase levels in bronchoalveolar lavage fluid from newborn babies. Pediatr Res 2001;50:29-33.
19. Danan C, Jarreau PH, Franco ML, Dassieu G, Grillon C, Abd Alsamad I, Lafuma C, Harf A, Delacourt C: Gelatinase activities in the airways of premature infants and development of bronchopulmonary dysplasia. Am J Physiol 2002;283:L1086-L1093.
20. Jobe AH, Bancalari E: Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163: 1723-1729.
21. Dik WA, Zimmermann LJ, Naber BA, Janssen DJ, Van Kaam AH, Versnel MA: Thrombin contributes to bronchoalveolar lavage fluid mitogenicity in lung disease of the premature infant. Pediatr Pulmonol 2003;35:34-41.
22. de Blic J, Midulla F, Barbato A, Clement A, Dab I, Eber E, Green C, Grigg J, Kotecha S, Kurland G, Pohunek P, Ratjen F, Rossi G: Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur Respir J 2000;15:217-231.
23. Delacourt C, D'Ortho MP, Macquin-Mavier I, Pezet S, Harf A, Lafuma C: Increased 92 kD gelatinase activity from alveolar macrophages in newborn rats. Am J Respir Crit Care Med 1995;151:1939-1945.
24. Lemjabbar H, Gosset P, Lechapt-Zalcman E, Franco-Montoya ML, Wallaert B, Harf A, Lafuma C: Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis: Effects of steroid and immunosuppressive treatment. Am J Respir Cell Mol Biol 1999;20:903-913.
25. Fukuda Y, Ishizaki M, Okada Y, Seiki M, Yamanaka N: Matrix metalloproteinases and tissue inhibitor of metalloproteinase-2 in fetal rabbit lung. Am J Physiol 2000;279:L555-L561.
26. Ekekezie, II, Thibeault DW, Simon SD, Norberg M, Merrill JD, Ballard RA, Ballard PL, Truog WE: Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease. Pediatrics 2004;113:1709-1714.
27. Sweet DG, Curley AE, Chesshyre E, Pizzotti J, Wilbourn MS, Halliday HL, Warner JA: The role of matrix metalloproteinases -9 and -2 in development of neonatal chronic lung disease. Acta Paediatr 2004;93:791-796.
28. Curley AE, Sweet DG, Thornton CM, O'Hara MD, Chesshyre E, Pizzotti J, Wilbourn MS, Halliday HL, Warner JA: Chorioamnionitis and increased neonatal lung lavage fluid matrix metalloproteinase-9 levels: implications for antenatal origins of chronic lung disease. Am J Obstet Gynecol 2003;188:871-875.